← Leaderboards
Vandana Abramson
Vanderbilt University
$1,607,470
Attributed
$4,583,690
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $750.5K · FY2010–18$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$4,583,690 · 2
By mechanism
U01$4,030,915 · 1
R21$552,775 · 1
Top collaborators
- Thomas E Yankeelov10 shared
- Richard G Abramson5 shared
- Gregory S Karczmar5 shared
- Rita Nanda5 shared
- Ana M. Gonzalez-Angulo2 shared
- Nancy U Lin2 shared
- Funda Meric-Bernstam2 shared
Most similar at Vanderbilt University
Same institution · by research overlap
- Lynn M Matrisian$19,522,211
- Jennifer A Pietenpol$43,416,854
- Yu Shyr$30,935,638
- Harold L Moses$33,288,478
- Carlos L Arteaga$27,881,034
Others in their field
Top investigators on “Breast”
- David Heimbrook · Leidos Biomedical Research, Inc.$373,324,203
- Norman Wolmark · Nsabp Foundation, Inc.$299,443,204
- Carol Nesel · Westat$147,274,423
- Richard L Schilsky · University Of Chicago$122,521,723
- Walter John Curran · Thomas Jefferson University$115,541,960
- J Brooks Jackson · Social And Scientific Systems, Inc.$111,373,799
Research focus
BreastMalignant Breast NeoplasmInhibitor/AntagonistResponseClinical TrialsTreatment ResponseBreast Cancer TreatmentMammary NeoplasmsCisplatinPaclitaxelCommunitiesMagnetic Resonance ImagingImageUser-FriendlyNeoadjuvant TherapyHealthcareCell ProliferationAlgorithmsApoptosisTranslationsTumorMolecularDiffusion Magnetic Resonance ImagingBiomarker
Grant awards (13)
Quantitative MRI for Predicting Response of Breast Cancer to Neoadjuvant Therapy$461,172
U01 · FY2018 · CA
Quantitative MRI for Predicting Response of Breast Cancer to Neoadjuvant Therapy$461,999
U01 · FY2017 · CA
Quantitative MRI for Predicting Response of Breast Cancer to Neoadjuvant Therapy$462,791
U01 · FY2016 · CA
Quantitative MRI for Predicting Response of Breast Cancer to Neoadjuvant Therapy$293,260
U01 · FY2015 · CA
Quantitative MRI for Predicting Response of Breast Cancer to Neoadjuvant Therapy$169,657
U01 · FY2015 · CA
PET-MRI for Assessing Treatment Response in Breast Cancer Clinical Trials$424,053
U01 · FY2014 · CA
PET-MRI for Assessing Treatment Response in Breast Cancer Clinical Trials$412,115
U01 · FY2013 · CA
PET-MRI for Assessing Treatment Response in Breast Cancer Clinical Trials$439,708
U01 · FY2012 · CA
Akt Inhibitor MK-2206 for Breast Cancers with a PIK3CA Mutation and/or PTEN loss$262,015
R21 · FY2012 · CA
PET-MRI for Assessing Treatment Response in Breast Cancer Clinical Trials$48,822
U01 · FY2012 · CA
PET-MRI for Assessing Treatment Response in Breast Cancer Clinical Trials$440,658
U01 · FY2011 · CA
Akt Inhibitor MK-2206 for Breast Cancers with a PIK3CA Mutation and/or PTEN loss$290,760
R21 · FY2011 · CA
PET-MRI for Assessing Treatment Response in Breast Cancer Clinical Trials$416,680
U01 · FY2010 · CA